These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 19034054

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, Young RL, Wells EC, O'Sullivan MJ, Chen B, Schenken R, Johnson SR, Women's Health Initiative Investigators.
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
    Tseng LH, Wang AC, Chang YL, Soong YK, Lloyd LK, Ko YJ.
    Neurourol Urodyn; 2009 May; 28(1):47-51. PubMed ID: 19089890
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.
    Freedman M, Kaunitz AM, Reape KZ, Hait H, Shu H.
    Menopause; 2009 May; 16(4):735-41. PubMed ID: 19252451
    [Abstract] [Full Text] [Related]

  • 13. Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women.
    Utian W, Yu H, Bobula J, Mirkin S, Olivier S, Pickar JH.
    Maturitas; 2009 Aug 20; 63(4):329-35. PubMed ID: 19647382
    [Abstract] [Full Text] [Related]

  • 14. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
    Wu MH, Pan HA, Wang ST, Hsu CC, Chang FM, Huang KE.
    Climacteric; 2001 Dec 20; 4(4):314-9. PubMed ID: 11770188
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
    El-Hage G, Eden JA, Manga RZ.
    Climacteric; 2007 Aug 20; 10(4):335-43. PubMed ID: 17653960
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of the addition of methyltestosterone to combined hormone therapy with estrogens and progestogens on sexual energy and on orgasm in postmenopausal women.
    Penteado SR, Fonseca AM, Bagnoli VR, Abdo CH, Júnior JM, Baracat EC.
    Climacteric; 2008 Feb 20; 11(1):17-25. PubMed ID: 18202961
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
    Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J.
    Menopause; 2009 Feb 20; 16(5):923-31. PubMed ID: 19424093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.